@ShahidNShah
Tech startups developing rapid COVID-19 tests to be taken completely at home
Computer vision company Gauss teamed up with biotechnology company Cellex to develop a rapid, at-home and point-of-care COVID-19 antigen test.
While there are other at-home COVID-19 diagnostic tests available, at least two companies are working on rapid antigen tests that can be performed by people at home without involving a laboratory.
The Gauss and Cellex test has not yet gained Food and Drug Administration (FDA) approval. The companies are pushing for FDA Emergency Use Authorization (EUA) some time this fall.
Sona Nanotech, based in Halifax, Canada, is awaiting FDA approval for its rapid detection COVID-19 antigen test. The test utilizes a nasopharyngeal swab and provides a result in 15 minutes without the use of either laboratory equipment or a reader, according to the company.
There is a growing consensus among public health officials and business leaders that a widely-accessible rapid antigen testing solution is needed to decrease the public health threat from COVID-19 and mitigate the pandemic’s economic impact until a vaccine is widely available.
Continue reading at fiercehealthcare.com
Make faster decisions with community advice
- DrDoctor raises £3m to expand digital patient services platform
- How Does Your EHR Affect Quality and Outcomes?
- Ransomware Attack at Hospital Leads to Patient's Death
- Shifting healthcare pay model to prioritize essential workers
- Tech startups developing rapid COVID-19 tests to be taken completely at home
Next Article
-
DrDoctor raises £3m to expand digital patient services platform
The startup will use the funding to help expand its platform of patient communication and digital care solutions. London-based startup DrDoctor has secured £3m in Series A investment from venture …
Posted Sep 18, 2020 Digital Health Patient Engagement